Matti Sällberg: We’re going to see an explosion of ATMPs coming to the benefit of patients
Advanced Therapy Medicinal Products (ATMPs) are revolutionizing healthcare, and in Stockholm and Flemingsberg, we're experts in this field. Listen to Matti Sällberg, professor and dean at Karolinska Institutet South, as he shares insights on how we're translating these scientific advancements from the lab to the clinic and changing lives. A film made by Stockholm Business Region.
The field of Advanced Therapy Medicinal Products (ATMPs) is revolutionizing medicine. These cutting-edge biological treatments, based on cells, tissues, and genes, hold immense promise for curing diseases in ways traditional medicines couldn’t. ATMPs offer one-time treatments with lasting effects. For some cancer patients who’ve exhausted other options, they provide hope for long-term survival. Additionally, ATMPs address hereditary diseases where current treatments fall short.
Professor and Dekan Matti Sallberg at Karolinska Institutet shares insights on Stockholm’s ATMP advancements. “We really are taking advantage of the discoveries made in basic science, and now translating them in a quite smooth way into human use. So I think within the next ten years, we’re going to see an explosion of ATMPs coming to the benefit of patients.,” he emphasizes.
Most of the text and the entire film were created and produced by Stockholm Business Region.

Hitchhiker’s Guide to Startup Success: Mastering the Art of the Perfect Pitch
Earlier this fall, we launched the first event in our seminar series, Hitchhiker’s Guide to Startup Success, which we are organizing together with Miltenyi Biotec. The inaugural session featured an inspiring workshop led by pitch expert and coach Malcolm Larri. The event gathered innovators and entrepreneurs in the Life Sciences sector, with a particular focus on Advanced Therapy Medicinal Products (ATMP)—a rapidly growing field with tremendous potential to revolutionize healthcare.
Key2Compliance Becomes a Trusted Partner in Strategic Collaboration to Advance ATMP and Life Science Development in Flemingsberg
Key2Compliance has become a Trusted Partner to Flemingsberg Science Foundation, a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.
AWA Becomes a Trusted Partner in Strategic Collaboration to Advance ATMP and Life Science Development in Flemingsberg
AWA has become a Trusted Partner to Flemingsberg Science Foundation, a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.
Flemingsberg’s Role in Advancing Life Science in Southern Stockholm
During Almedalen week this year, we had the opportunity to delve into Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. The purpose of the roundtable discussion was to raise awareness about Flemingsberg’s development in life science and create a platform for the exchange of experiences. We shared valuable insights on how Flemingsberg can become one of Sweden’s most significant centers for education, research, and creativity.